Improved Transplantation Strategy for Mouse Mesenchymal Stem Cells in Heart Attack Model
Author Information
Author(s): Jin Jianliang, Zhao Yingming, Tan Xiao, Guo Chun, Yang Zhijian, Miao Dengshun
Primary Institution: Nanjing Medical University
Hypothesis
The 1st BM-MSCs amplified using the 'Pour-off' method would be superior to repeat passage BM-MSCs in terms of the potency of proliferation and differentiation.
Conclusion
Transplantation of the 1st BM-MSCs may be a more effective therapeutic strategy for cardiac tissue regeneration following acute myocardial infarction compared to the 5th passage BM-MSCs.
Supporting Evidence
- The 1st BM-MSCs showed better therapeutic effects in the mouse MI model compared to the 5th passage BM-MSCs.
- 1st BM-MSCs maintained greater differentiation potentials towards cardiomyocytes or vascular endothelial cells in vitro.
- Transplantation of the 1st BM-MSCs resulted in improved cardiac function and reduced myocardial fibrosis.
Takeaway
This study found that using fresh stem cells from mice helps heal heart damage better than using older, repeatedly cultured stem cells.
Methodology
Primary mouse BM-MSCs and 5th passage BM-MSCs were transplanted into a mouse model of acute myocardial infarction, and their effects were compared after 6 weeks.
Potential Biases
Potential bias in the selection of stem cell types and the interpretation of results.
Limitations
The study was conducted in a mouse model, which may not fully replicate human conditions.
Participant Demographics
Adult C57BL/6J and β-gal transgenic mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website